Case Study: Medical Plan

838 Words4 Pages
Assignment B6: Marketing Phase

1. BRAND NAME OF THE NEW MEDICINE
The name of our new drug is Nervarin® (salizumab).

Package design:

PACKAGE INSERT
Chapter A: Medical Plan (Hiba Saleh)

The differences Phase III and Phase IV clinical studies
Phase III is carried out on a large scale of patients in different countries. The patient population can exceed 30,000. Phase III tests the ultimate safety, efficacy and dosage of drugs as compared to the current standard treatment or placebo. The chance of success in phase III is small. Almost 80 percent of the drugs that do enter phase III trials move on to phase IV trials. Phase IV on the other hand, is carried out after the drug has entered the pharmaceutical market and involves real world data

More about Case Study: Medical Plan

Open Document